About 2 results found for searched term "Olverembatinib" (0.205 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M2749 | GZD824 Dimesylate | Src-bcr-Abl |
| Olverembatinib Dimesylate | ||
| GZD824 is a third-generation oral effective BCR-ABL inhibitor, acting on BCR-ABL (WT) and BCR-ABL (T315I) with IC50 of 0.34 nM and 0.68 nM, respectively. | ||
| M6305 | Olverembatinib | Src-bcr-Abl |
| GZD824; HQP1351 | ||
| Olverembatinib is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
